Protalix BioTherapeutics Inc (PLX)

2.27 +0.03 (+1.34%) USD  |  NYAM  |  Jan 08, 16:00
2.265 0.00 (0.00%) After-Hours: 20:00
More

Protalix BioTherapeutics Cash and Short Term Investments (Annual): 44.56M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Accuray Inc 68.57M
AIM ImmunoTech Inc 13.07M
Perspective Therapeutics Inc 9.238M
Electromed Inc 16.08M
Armata Pharmaceuticals Inc 13.52M